FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, namely a new alpha-conotoxin PnIA analogue showing high affinity and selectivity to acetylcholine-binding protein (ACBP) form Aplysia californica. The peptide has an amino acid sequence: GCCSHPPCAANNPDYC-NH2 (SEQ ID NO:1) and contains two intramolecular disulphide bonds between Cys2 and Cys8, Cys3 and Cys16.
EFFECT: invention allows extending the range the substances which appear to be competitive antagonists of acetylcholine nicotinic receptor.
3 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE HAVING HIGH AFFINITY TO TYPE ALPHA7 HUMAN NICOTINIC RECEPTOR AND USE THEREOF | 2011 |
|
RU2455359C1 |
ANALOGUE OF ALPHA-CONOTOXIN RGIA FOR TREATING PAIN | 2016 |
|
RU2731217C2 |
PEPTIDE AZEMYOPSYN SELECTIVELY REACTING WITH NICOTINE MUSCARINIC RECEPTORS AND APPLICABLE AS MYORELAXANT IN MEDICINE AND COSMETOLOGY | 2011 |
|
RU2473559C1 |
PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
POLYPEPTIDE DEMONSTRATING ANTIBACTERIAL ACTIVITY AND SUITABLE FOR OBTAINING THERAPEUTIC MEDICATIONS FOR TREATMENT OF HUMAN BACTERIAL INFECTIONS | 2010 |
|
RU2434880C1 |
PEPTIDES BINDING VASCULAR ENDOTHELIUM GROWTH FACTOR | 2019 |
|
RU2739246C1 |
ANTIBODIES AGAINST ALPHA SYNUCLEIN | 2018 |
|
RU2787039C2 |
HEMAGGLUTININ-CONTAINING CHIMERIC VIRUS-LIKE PARTICLES, SIMILAR TO PARTICLES OF FLU VIRUS | 2010 |
|
RU2569195C9 |
CONJUGATES OF PEPTIDE AND POLYAMINO ACID, BINDING VESSEL ENDOTHELIUM GROWTH FACTOR | 2020 |
|
RU2781974C2 |
INHIBITORS OF XA FACTOR | 1995 |
|
RU2152954C1 |
Authors
Dates
2012-08-10—Published
2011-02-10—Filed